{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477002878
| IUPAC_name = disodium (pyridin-2-ylmethylene)di-4,1-phenylene disulfate
| image = Sodium picosulfate.svg
| width = 260
| image2 = Sodium picosulfate ions ball.png
| alt2 = Ball-and-stick model of the component ions of sodium picosulfate
| width2 = 240

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|international|sodium-picosulfate}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 10040-45-6
| ATC_prefix = A06
| ATC_suffix = AB08
| ATC_supplemental = <br />{{ATC|A06|AB58}} (combinations)
| PubChem = 68654
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 61910
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = LR57574HN8

<!--Chemical data-->
| C=18 | H=13 | N=1 | Na=2 | O=8 | S=2
| molecular_weight = 481.409 g/mol
| smiles = [Na+].[Na+].[O-]S(=O)(=O)Oc1ccc(cc1)C(c2ccc(OS([O-])(=O)=O)cc2)c3ncccc3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H15NO8S2.2Na/c20-28(21,22)26-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(11-7-14)27-29(23,24)25;;/h1-12,18H,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GOZDTZWAMGHLDY-UHFFFAOYSA-L
}}
'''Sodium picosulfate''' ([[International Nonproprietary Name|INN]], also known as '''sodium picosulphate''') is a contact [[stimulant laxative]] used as a treatment for [[constipation]] or to prepare the large bowel before [[colonoscopy]] or [[surgery]]. It is sold under the trade names '''Sodipic Picofast''', '''Laxoberal''', '''Laxoberon''',<ref>[http://www.merck.pk/en/pharmaceutical_products/merck_serono/Copy_of_neurocare/laxoberon/laxoberon.html Website of Merck Pakistan]</ref>  '''Purg-Odan''', '''Picolax''', '''Guttalax''', '''Namilax''', '''Pico-Salax''',<ref>[http://www.pico-salax.ca/product-information.html PICO SALAX Product Information]</ref> '''PicoPrep''',<ref>{{cite journal|journal = [[Diseases of the Colon & Rectum]]|year = 2006|volume = 49|issue = 5|pages = 616-620|title = Oral sodium phosphate (Fleet<sup>(R)</sup>) is a superior colonoscopy preparation to Picoprep<sup>(R)</sup> (sodium picosulfate-based preparation)|last1 = Tjandra|first1 = Joe J.|last2 = Chan|first2 = Miranda|last3 = Tagkalidis|first3 = Peter P.|pmid = 16525746|doi = 10.1007/s10350-005-0323-2}}</ref> and '''Prepopik''',<ref name = FDA /> among others.

==Effects==
Orally administered sodium picosulfate is generally used for thorough evacuation of the bowel, usually for patients who are preparing to undergo a colonoscopy. It takes 12–24 hours to work, since it works in the colon.<ref name = FDA>{{cite web|publisher = [[Food and Drug Administration]]|url = http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312315.htm|title = FDA News Release &ndash; FDA approves new colon-cleansing drug for colonoscopy prep|date = July 17, 2012|accessdate = December 1, 2016}}</ref>

Abdominal cramps and diarrhea are normal effects of picosulfate and should be expected.

The use of sodium picosulfate has also been associated with certain [[electrolyte disturbance]]s, such as [[hyponatremia]] and [[hypokalemia]].<ref>{{cite journal |date=February 2002 | title = Electrolyte disturbances with sodium picosulfate bowel cleansing products | author = [[Adverse Drug Reactions Advisory Committee|ADRAC]] | journal = Aust Adv Drug React Bull | volume = 21 | issue = 1}} [http://www.tga.gov.au/adr/aadrb/aadr0202.htm#elec Free full text] from the [[Australia]]n [[Therapeutic Goods Administration]]</ref> Patients are often required to drink large amounts of clear fluids as well as rehydrate to reestablish the electrolyte balance.

== Mechanism of action ==
Sodium picosulfate is a [[prodrug]].<ref name=":1">{{Cite journal|title = Mechanism of action and toxicities of purgatives used for colonoscopy preparation|url = http://www.tandfonline.com/doi/abs/10.1517/17425255.2011.542411|journal = Expert Opinion on Drug Metabolism & Toxicology|date = 2011-01-01|issn = 1742-5255|pmc = 3030244|pmid = 21162694|pages = 89–101|volume = 7|issue = 1|doi = 10.1517/17425255.2011.542411|first = Margaret|last = Adamcewicz|first2 = Dilip|last2 = Bearelly|first3 = Gail|last3 = Porat|first4 = Frank K.|last4 = Friedenberg}}</ref> It has no significant direct physiological effect on the intestine; however, it is metabolised by [[gut bacteria]] into the active compound 4,4'-dihydroxydiphenyl-(2-pyridiyl)methane (DPM, BPHM).<ref name=":1"/><ref name=":0">{{Cite journal|title = The hydragogue and laxative effect of the sulfuric acid ester and the free diphenol of 4,4′-dihydroxydiphenyl-(pyridyl-2)-methane|url = https://link.springer.com/article/10.1007/BF00501005|journal = Naunyn-Schmiedeberg's Archives of Pharmacology|date = 1972-03-01|issn = 0028-1298|pages = 46–53|volume = 274|issue = 1|doi = 10.1007/BF00501005|first = W.|last = Forth|first2 = G.|last2 = Nell|first3 = W.|last3 = Rummel|first4 = H.|last4 = Andres}}</ref> This compound is a [[stimulant laxative]] and increases [[peristalsis]] in the gut.<ref name=":1"/><ref>{{cite journal|last1=Jauch|first1=R|last2=Hankwitz|first2=R|last3=Beschke|first3=K|last4=Pelzer|first4=H|title=Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.|journal=Arzneimittel-Forschung|date=November 1975|volume=25|issue=11|pages=1796–1800|pmid=1243088}}</ref>

Sodium picosulfate is typically prescribed in a combined formulation with [[magnesium citrate]], an [[osmotic laxative]]. This combination is a highly effective laxative, often prescribed to patients for bowel cleansing prior to [[Colonoscopy|colonoscopies]].<ref name=":1"/><ref>{{Cite journal|title = Comparison of two bowel preparations for colonoscopy: sodium picosulphate with magnesium citrate versus sulphate-free polyethylene glycol lavage solution|url = http://www.nature.com/doifinder/10.1111/j.1572-0241.1998.00467.x|journal = The American Journal of Gastroenterology|pages = 1478–1482|volume = 93|issue = 9|doi = 10.1111/j.1572-0241.1998.00467.x|first = Arie|last = Regev|first2 = Gerald|last2 = Fraser|first3 = George|last3 = Delpre|first4 = Alfredo|last4 = Leiser|first5 = Ami|last5 = Neeman|first6 = Eran|last6 = Maoz|first7 = Victor|last7 = Anikin|first8 = Yaron|last8 = Niv}}</ref>

==References==
{{Reflist}}

{{Laxatives}}

[[Category:Pyridines]]
[[Category:Laxatives]]
[[Category:Organosulfates]]
[[Category:Organic sodium salts]]